Page last updated: 2024-11-05

thiotepa and Neuroectodermal Tumors

thiotepa has been researched along with Neuroectodermal Tumors in 1 studies

Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).

Neuroectodermal Tumors: Malignant neoplasms arising in the neuroectoderm, the portion of the ectoderm of the early embryo that gives rise to the central and peripheral nervous systems, including some glial cells.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Thust, SC1
Blanco, E1
Michalski, AJ1
Chong, WK1
Gaze, MN1
Phipps, K1
Mankad, K1

Other Studies

1 other study available for thiotepa and Neuroectodermal Tumors

ArticleYear
MRI abnormalities in children following sequential chemotherapy, hyperfractionated accelerated radiotherapy and high-dose thiotepa for high-risk primitive neuroectodermal tumours of the central nervous system.
    Journal of medical imaging and radiation oncology, 2014, Volume: 58, Issue:6

    Topics: Adolescent; Antineoplastic Agents, Alkylating; Brain Injuries; Brain Neoplasms; Chemoradiotherapy; C

2014